Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Patricia Londoño-Hayes"'
Autor:
Simon Delagrave, Hector Hernandez, Changhong Zhou, John F Hamberger, Sophia T Mundle, John Catalan, Simge Baloglu, Stephen F Anderson, Joshua M DiNapoli, Patricia Londoño-Hayes, Mark Parrington, Jeffrey Almond, Harry Kleanthous
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46714 (2012)
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwide, causing a range of symptoms that result in significant healthcare costs and human suffering. ACAM529 is a replication-defective vaccine candidate
Externí odkaz:
https://doaj.org/article/c5ec100bcc5544109ee42bf24ad11d78
Publikováno v:
Nature reviews. Drug discovery. 17(11)
Since its launch a decade ago, the European Innovative Medicines Initiative (IMI), a leading public–private partnership in life sciences, has catalysed scientific breakthroughs and the development of strategies to address complex challenges in vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20654de4cce4f1fef92e6fe0ba2923a
https://pubmed.ncbi.nlm.nih.gov/29853715
https://pubmed.ncbi.nlm.nih.gov/29853715
Autor:
Patricia J Pietrobon, Nadège Arnaud-Barbe, Nadine Petiot, Laurence Quemeneur, Patricia Londoño-Hayes, Catherine Hessler
Publikováno v:
Infection and Immunity
Clostridium difficile infection (CDI) is a leading cause of nosocomial and antibiotic-associated diarrhea. A vaccine, based on formalin-inactivated toxins A and B purified from anaerobic cultures of C. difficile strain VPI 10463 (toxinotype 0), has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8571ff97b0a6358d46dbccee27200ec0
https://doi.org/10.1128/iai.00742-17
https://doi.org/10.1128/iai.00742-17
Autor:
Marie-Clotilde Bernard, Fabrine Pradezynski, Catherine Caillet, Ryall Robert P, Aymeric de Montfort, Veronique Barban, Patricia Londoño-Hayes
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121518 (2015)
PLoS ONE
PLoS ONE
HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1405a943274a095694e56b2d8c9ae47b
http://europepmc.org/articles/PMC4383384?pdf=render
http://europepmc.org/articles/PMC4383384?pdf=render
Autor:
Sophia Mundle, Stephen Anderson, Simge Baloglu, John Hamberger, Joshua M. DiNapoli, Hector Hernandez, John Catalan, Harry Kleanthous, Simon Delagrave, Mark Parrington, Changhong Zhou, Patricia Londoño-Hayes, Jeffrey Almond
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46714 (2012)
PLoS ONE
PLoS ONE
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwide, causing a range of symptoms that result in significant healthcare costs and human suffering. ACAM529 is a replication-defective vaccine candidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee93a6ca5c2db3690adaad6d8d8b460f
http://europepmc.org/articles/PMC3469653?pdf=render
http://europepmc.org/articles/PMC3469653?pdf=render